Primary record
TGF-beta RI kinase inhibitor II (2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine)
- 库存
- 4,472 克
- 纯度
- 98.8 %
- CAS
- 446859-33-2
化合物标识与属性
- CAS
- 446859-33-2
- PubChem CID
- 449054
- SMILES
- CC1=NC(=CC=C1)C2=C(C=NN2)C3=NC4=C(C=C3)N=CC=C4
- Canonical SMILES
- Cc1cccc(-c2[nH]ncc2-c2ccc3ncccc3n2)n1
名称与同义词
- RepSox
- 446859-33-2
- ALK5 Inhibitor II
- ALK5 Inhibitor
- 1vjy
- RepSox (GMP)
- Alk 5 Inhibitor II
- TGF-Beta
- 2-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine
- SJN 2511
- JT8ZW3H2ST
- RefChem:879262
- RepsoxALK5 Inhibitor II
- C17H13N5
- RepsoxALK5 Inhibitor II?
- SJN-2511
- AC1L9MO3
- CHEMBL185238
- MFCD09037561
- cc-232
- GW786460X (Repsox)
- MLS006011123
- SCHEMBL144632
- RepSox (ALK5 Inhibitor II)
- GW786460X
- TGF-beta RI Kinase Inhibitor II
- orb1300856
- SCHEMBL16969100
- SCHEMBL29360592
- SCHEMBL29373253
- SCHEMBL29398528
- ALK5 Inhibitor II hydrochloride
- CTK8E7448
- RepSox, >=98% (HPLC)
- AOB1483
- DTXSID80332295
- E-616452
- SJN2511
- CHEBI:190969
- LBPKYPYHDKKRFS-UHFFFAOYSA-N
- HMS2043P13
- HMS3261N03
- HMS3653M19
- AMY20099
- BCP04103
- EX-A2879
- 2-[5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine
- Tox21_500541
- ABP000974
- BDBM50151347
- CID449054
- HB3301
- HY-13012G
- IN1052
- NSC756354
- s7223
- ZINC16052804
- AKOS016009677
- BCP9000274
- CCG-221845
- CS-1321
- FR44793
- NSC-756354
- RL03695
- SDCCGGSK-0000063.P001
- E 616452
- NCGC00242054-01
- NCGC00242054-02
- NCGC00242054-03
- NCGC00242054-17
- NCGC00261226-01
- 4CA-1165
- AC-28395
- AJ-68089
- AJ-68090
- AK-35200
- AS-16653
- DA-42419
- EN002636
- HY-13012
- SC-96580
- SMR004702903
- SY240315
- 2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine
- BCP0726000102
- AB0007897
- A3754
- CS-0617970
- E616452
- FT-0759246
- R0224
- SW212662-2
- X5942
- J3.095.272C
- J3.496.867E
- A11762
- W-5394
- 1,5-Naphthyridine, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-
- AB01092249-01
- A872478
- F237399
- GW786460X (616452)
- 2-[3-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine
- BRD-K80480517-001-02-4
- 2-(3-(6-Methylpyridine-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine
- 3-(2-CARBOXYETHYL)-2,5-DIMETHYLBENZOXAZOLIUMBROMIDE
- 4-(1,5-Diaza-2-naphthyl)-3-(6-methyl-2-pyridyl)pyrazole
- B0084-068993
- Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor II
- 2-[3-(6-Methyl-2-pyridyl)-4-pyrazolyl]-1,5-naphthyridine
- 2-(3-(6-methyl-2-pyridinyl)-1h-pyrazol-4-yl)-1,5-naphthyridine
- 2-(5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine
- 2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazole-4-yl]-1,5-naphthyridine
- 2-[3-(6-Methyl-2-pyridyl)-1H-pyrazole-4-yl]-1,5-naphthyridine
- 2-[3-(6-methylpyridin-2-yl)-2H-pyrazol-4-yl]-1,5-naphthyridine
- 2-[3-(6-Methylpyridine-2-yl)-1H-pyrazole-4-yl]-1,5-naphthyridine
- 2-[5-(6-methyl-2-pyridyl)-1H-pyrazol-4-yl]-1,5-naphthyridine
- 2-[5-(6-Methylpyridine-2-yl)1H-pyrazole-4-yl]-1,5-naphthyridine
- 2-[3-(6-Methyl-pyridin-2-yl)-1H-pyrazol-4-yl]-[1,5]naphthyridine
- 2-[5-(6-METHYLPYRIDIN-2-YL)-2,3-DIHYDRO-1H-PYRAZOL-4-YL]-1,5-NAPHTHYRIDINE
- Alk 5 Inhibitor II (2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine)
- E-616452; 2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine
- E-616452;SJN 2511;E616452;SJN2511;E 616452;SJN-2511
- 2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine; E 616452; RepSox; SJN 2511
- 663-924-9
- TGF-beta RI kinase inhibitor II (2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine)